Soley Therapeutics
San Francisco
About Soley Therapeutics
Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs, using image acquisition-based approaches. Soley Therapeutics has taken an orthogonal approach to discover new drugs by developing a technology platform to measure how cells respond multi-dimensionally in response to drugs. We have developed a novel platform for high-content phenotypic drug screening, where the drug effect on a cell can be visualized via molecular-microscopic images and analyzed by using sophisticated AI tools.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $220.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2026)
- Website: soleytherapeutics.com
- Phone: +1 415-850-9841
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/soley-therapeutics-32241 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.